Discover
AZN
AstraZeneca PLC
183.86
300 x undefined
100 x undefined
bid
ask
-
5.76
3.04%
200 @ 06:16 AM
188.01 +4.15 (2.26%)
| Ytd | 0.00% | |
| 1y | 28.65% |
183.49
day range
187.56
137.22
52 week range
212.71
| Open | 187.07 | Prev Close | 189.62 | Low | 183.49 | High | 187.56 | Mkt Cap | 285.14B |
| Vol | 2.11M | Avg Vol | 1.98M | EPS | 6.64 | P/E | 27.69 | Forward P/E | 23.34 |
| Beta | 0.21 | Short Ratio | 0.68 | Inst. Own | 68.24% | Dividend | 3.16 | Div Yield | 1.67 |
| Ex Div Date | 02-20 | Earning | 07-27 | 50-d Avg | 184.21 | 200-d Avg | 183.29 | 1yr Est | 224.49 |
| Income Statement | |||
| Total Revenue | 15.29B | ||
| Revenues (USD) | 15.29B | ||
| Cost of Revenue | 2.68B | ||
| Gross Profit | 12.61B | ||
| Operating Expenses | 8.36B | ||
| Research and Development Expense | 3.49B | ||
| Selling, General and Administrative Expense | 5.06B | ||
| Operating Income | 4.25B | ||
| Interest Expense | 393.00M | ||
| Income Tax Expense | 833.00M | ||
| Net Income | 3.08B | ||
| Net Income Common Stock | 3.08B | ||
| Net Income Common Stock (USD) | 3.08B | ||
| Consolidated Income | 3.08B | ||
| Net Income to Non-Controlling Interests | 1000.00K | ||
| Earnings per Basic Share | 1.99 | ||
| Earnings per Basic Share (USD) | 1.99 | ||
| Earnings per Diluted Share | 1.97 | ||
| Dividends per Basic Common Share | 2.15 | ||
| Earning Before Interest & Taxes (EBIT) | 4.31B | ||
| Earning Before Interest & Taxes (USD) | 4.31B | ||
| Weighted Average Shares | 1.55B | ||
| Weighted Average Shares Diluted | 1.56B | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.56B | ||
| Cash and Equivalents (USD) | 7.56B | ||
| Investments | 2.78B | ||
| Investments Current | 115.00M | ||
| Investments Non-Current | 2.67B | ||
| Trade and Non-Trade Receivables | 15.29B | ||
| Current Assets | 29.61B | ||
| Property, Plant & Equipment Net | 14.94B | ||
| Total Assets | 114.02B | ||
| Debt Current | 7.96B | ||
| Total Debt | 33.92B | ||
| Current Liabilities | 32.57B | ||
| Debt Non-Current | 25.96B | ||
| Total Liabilities | 66.63B | ||
| Accumulated Retained Earnings (Deficit) | 9.67B | ||
| Shareholders Equity | 47.33B | ||
| Shareholders Equity (USD) | 47.33B | ||
| Assets Non-Current | 84.40B | ||
| Total Debt (USD) | 33.92B | ||
| Goodwill and Intangible Assets | 58.28B | ||
| Inventory | 6.57B | ||
| Liabilities Non-Current | 34.06B | ||
| Trade and Non-Trade Payables | 24.66B | ||
| Tax Assets | 8.19B | ||
| Tax Liabilities | 5.38B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.37B | ||
| Net Cash Flow from Financing | 267.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.83B | ||
| Capital Expenditure | -539.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -281.00M | ||
| Issuance (Purchase) of Equity Shares | -602.00M | ||
| Issuance (Repayment) of Debt Securities | 4.23B | ||
| Payment of Dividends & Other Cash Distributions | -3.29B | ||
| Net Cash Flow from Investing | -1.79B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -85.00M | ||
| Net Cash Flow from Operations | 3.36B | ||
| Effect of Exchange Rate Changes on Cash | -18.00M | ||